Ilias Katsikis

Thessaloniki, ESYE12, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

ENhancinG vAGinal dElivery in Greece through educational and behavioral interventions among maternity care providers regarding labor management: the ENGAGE stepped-wedge randomized prospective trial protocol.

ENhancinG vAGinal dElivery in Greece through educational and behavioral interventions among maternity care providers regarding labor management: the ENGAGE stepped-wedge randomized prospective trial protocol.

Journal: Trials

Published: October 13, 2023

Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.

Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.

Journal: Human reproduction (Oxford, England)

Published: November 01, 2015

The benefit-to-risk ratio of common treatments in PCOS: effect of oral contraceptives versus metformin on atherogenic markers.

The benefit-to-risk ratio of common treatments in PCOS: effect of oral contraceptives versus metformin on atherogenic markers.

Journal: Hormones (Athens, Greece)

Published: January 03, 2015

Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS).

Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS).

Journal: Hormones (Athens, Greece)

Published: April 30, 2014

Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndrome.

Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndrome.

Journal: Hormones (Athens, Greece)

Published: January 25, 2014

Uterine volume and endometrial thickness in the early follicular phase in patients with polycystic ovary syndrome.

Uterine volume and endometrial thickness in the early follicular phase in patients with polycystic ovary syndrome.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: December 12, 2013

Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.

Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.

Journal: Hormones (Athens, Greece)

Published: November 27, 2013

Infertility treatment in polycystic ovary syndrome: lifestyle interventions, medications and surgery.

Infertility treatment in polycystic ovary syndrome: lifestyle interventions, medications and surgery.

Journal: Frontiers of hormone research

Published: September 05, 2013

Associations of menstrual cycle irregularities with age, obesity and phenotype in patients with polycystic ovary syndrome.

Associations of menstrual cycle irregularities with age, obesity and phenotype in patients with polycystic ovary syndrome.

Journal: Hormones (Athens, Greece)

Published: July 28, 2013

Age- and body mass index-related differences in the prevalence of metabolic syndrome in women with polycystic ovary syndrome.

Age- and body mass index-related differences in the prevalence of metabolic syndrome in women with polycystic ovary syndrome.

Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology

Published: July 27, 2013

Effect of hyperglycemia and hyperinsulinemia on glutathione peroxidase activity in non-obese women with polycystic ovary syndrome.

Effect of hyperglycemia and hyperinsulinemia on glutathione peroxidase activity in non-obese women with polycystic ovary syndrome.

Journal: Hormones (Athens, Greece)

Published: June 27, 2013

The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.

The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.

Journal: Clinical endocrinology

Published: May 14, 2013

Showing 1-12 of 26

Last Updated: 09/26/2026